🇺🇸 FDA
Pipeline program

rSIFN-co

rSIFN-01

Phase 1 small_molecule completed

Quick answer

rSIFN-co for Carcinoma, Non-Small-Cell Lung is a Phase 1 program (small_molecule) at Sichuan Provincial People's Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Sichuan Provincial People's Hospital
Indication
Carcinoma, Non-Small-Cell Lung
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials